The fate of inhaled drugs: The pharmacokinetics and pharmacodynamics of drugs administered by aerosol

Respiratory Care

Volumn 45, Issue 7, 2000, Pages 826-830

  Witek Jr , Theodore J ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Aerosols; Albuterol; Inhalation therapy; Inhaled corticosteroids; Pharmacokinetics; Tiotropium

Indexed keywords

BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; SALBUTAMOL; SCOPOLAMINE DERIVATIVE; TIOTROPIUM;

AEROSOL; ASTHMA; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CHOLINERGIC AGENTS; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME;

EID: 0034220657     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Benet LZ, Milchell JR, Sheiner LB. General principles. In: Gilman AG, Rail TW, Nies AS, Taylor P, editors. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: Persamon Press; 1990: 1-2.
2. Witek TJ, Schachter EN. Respiratory care pharmacology and therapeutics. Philadelphia: WB Saunders; 1994.
3. Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA, McDevitt DG. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 1989;37(6):567-571.
4. Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981:36(1):52-55.
5. Borgström L, Nilsson M. A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline. Pharm Res 1990;7(10):1068-1070.
6. Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhaltion. Br J Clin Pharmacol 1992;34(4):311-315.
7. Hindle M, Newton DAG, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax 1993;48(6): 607-610.
8. Kelly HW. Establishing a therapeutic index for the inhaled corticosteroids. Part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids (review). J Allergy Clin Immunol 1998; 102(4 Pt 2):S36-S51.
9. Barnes PJ. Inhaled glucocorticoids for asthma (review). N Engl J Med 1995;332(13):868-875.
10. Selroos O, Halme M. Effect of a Volumatic spacer and mouth rising on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax 1991;46(12):891-894.
11. Witek TJ, Souhrada JF, Serby CW, Disse B. Tiotropium (Ba679): pharmacology and early clinical observations. In: Spector SS, editor. Anticholinergic agents in the upper and lower airways. New York: Marcel Dekker; 1999: 137-152.
12. Disse B, Reichel R, Speck G, Traunecker W, Ludwig Rominger KL, Hammer R. Ba679BR. a novel long acting anticholinergic bronchodilator. Life Sci 1993;52(5-6):537-544.
13. Disse B, Speck G, Rominger KL, Witek TJ Jr, Hammer R. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstrutive lung disease (review). Life Sci 1999;64(6-7):457-464.
14. Maesen FPV, Smeets JJ, Costongs MAL, Wald FDM, Cornelissen PJG. BA 679BR. a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study in COPD. Eur Respir J 1993;6(7):1031-1036.
15. Littner MR, Ilowite JS, Tashkin DP, Friedman M, Serby CW, Menjoge SS, Witek TJ. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161(4 Pt 1): 1136-1142.
16. O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996;154(4 Pt 1):876-880.